Wankadi

Based in Haining, China and founded in 2026, Wankadi (Haining) Medical Equipment Co. , Ltd. , trading as Wankadi, focuses on the research and development of innovative electrocardiogram (ECG) monitoring and diagnostic technologies and intelligent medical services. In January 2026, Wankadi closed Angel funding from new investor Goldport Capital.

The company possesses innovative technologies such as 3D electrocardiography, high-frequency electrocardiography, and ventricular late potentials, which can improve diagnostic accuracy, reduce the demands of exercise testing, and increase the success rate of early disease screening. Combined with dynamic ECG acquisition technology and AI diagnostic models, these technologies effectively address the shortcomings of existing products, such as unclear diagnostic guidance, high rates of missed diagnoses and misdiagnoses, poor early screening results, and high risk during stress tests. The company generates revenue by doing R&D, and providing intelligent medical equipment and other related services. The Angel funding raised in January 2026 will be used to support Wankadi's innovative research and development in the field of electrocardiogram monitoring and diagnostic technology, and to promote the rapid development of intelligent medical services.